RE
KERX

RBC Europe’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

RBC Europe’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-950
Closed -$3.23K – 1168
2018
Q3 		$3.23K Hold
950
– – ﹤0.01% 1009
2018
Q2 		$3.57K Hold
950
– – ﹤0.01% 1009
2018
Q1 		$3.89K Hold
950
– – ﹤0.01% 989
2017
Q4 		$4.42K Hold
950
– – ﹤0.01% 975
2017
Q3 		$6.75K Buy
+950
New +$6.83K ﹤0.01% 909

RBC Europe's KERX Position: Q4 2018 in Review

RBC Europe sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 950 shares — an estimated $3.23K sold.

RBC Europe first reported a position in KERX in Q3 2017 and held it in 5 quarters. The position peaked at $6.75K in Q3 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

  • RBC Europe reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • RBC Europe sold 950 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $3.23K.
  • RBC Europe first reported a position in Keryx Biopharmaceuticals Inc in Q3 2017 and held it in 5 quarters.
  • RBC Europe's Keryx Biopharmaceuticals Inc position peaked at $6.75K in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on RBC Europe's 13F filing for Q4 2018, filed 9 Nov 2023.